Bladder Regeneration Using a Smart Acellular Collagen Scaffold with Growth Factors VEGF, FGF2 and HB-EGF

Abstract

Tissue engineering may become an alternative to current bladder augmentation techniques. Large scaffolds are needed for clinically significant augmentation, but can result in fibrosis and graft shrinkage. The purpose of this study was to investigate whether smart acellular collagen-heparin scaffolds with growth factors (GFs) VEGF, FGF2, and HB-EGF enhance bladder tissue regeneration and bladder capacity in a large animal model of diseased bladder. Scaffolds of bovine type I collagen with heparin and VEGF, FGF2, and HB-EGF measuring 3.2 cm in diameter were prepared. In 23 fetal sheep, a bladder exstrophy was surgically created at 79 days of gestation. One week after birth (at full term), the bladder was reconstructed by primary closure (PC group) or using a collagen-heparin scaffold with GFs (COLGF group) and compared to a historical group reconstructed with a collagen scaffold without GFs (COL group). Functional (video urodynamics) and histological evaluation was performed 1 and 6 months after bladder repair. The overall survival rate was 57%. Cystograms were normal in all animals, except for low-grade reflux in all groups. Urodynamics showed no statistically significant differences in bladder capacity and compliance between groups. Histological evaluation at 1 month revealed increased urothelium formation, improved angiogenesis, and enhanced ingrowth of smooth muscle cells (SMCs) in the COLGF group compared to the COL group. At 6 months, improved SMC ingrowth was found in the COLGF group compared to the COL group; both scaffold groups showed normal urothelial lining and standard extracellular matrix development. Bladder regeneration using a collagen-heparin scaffold with VEGF, FGF2, and HB-EGF improved bladder tissue regeneration in a large animal model of diseased bladder. Larger GF-loaded constructs need to be tested to reach clinically significant augmentation.

Effect of Optimized Concentrations of Basic Fibroblast Growth Factor and Epidermal Growth Factor on Proliferation of Fibroblasts and Expression of Collagen

“…bFGF and EGF are the most widely studied growth factors. [ 17 18 ] bFGF stimulates the proliferation of fibroblasts. Moreover, Wang et al .…”

Antigen-free bovine cancellous bone loaded with recombinant human bone morphogenetic protein-2 for the repair of tibial bone defects in goat model

“…9,[31][32][33] There are many bioactive factors which can be added to the scaffold, for example BMP, 1,2,[14][15][16]34 other growth factors including VEGF, FGF-2, HB-EGF, PDGF-BB, etc. 33,[35][36][37][38] and drugs 23 such as icariin, 30 licochalcone, 39 alendronate 40 and so on, among which BMP is the most frequently used in bone materials. BMP has been proved to have a high efficacy of osteoinductivity; however, it is seldom used to promote bone formation alone by the reason of being easily diluted and degraded.…”

Application of Collagen Scaffold in Tissue Engineering: Recent Advances and New Perspectives

“…All of these methods are applicable for growth factors modified on a collagen-based scaffold. For example, VEGF, FGF-2 and heparin-binding epidermal growth factor (HB-EGF) were loaded on collagen scaffold by physical adsorption through soaking scaffolds in phosphate buffered saline (PBS) containing growth factors [93]. Li et al [94] fused stromal cell-derived factor-1α (SDF-1α) with a unique peptide of the collagen binding domain (CBD), so the CBD-SDF-1α can specifically bind to the collagen scaffold.…”